Table 3.

Pattern of Ceftriaxone Use in the Included Studies

S.n	Author Yr (Ref)	% of Patients Who Used the Specified Dose of Ceftriaxone Daily				% of Patients with Appropriate Daily Ceftriaxone Dose (%)	% of Patients Who Used the Specified Duration of Ceftriaxone					% of Patients with Appropriate Ceftriaxone Duration (%)
		< 2gm	2gm	3gm	4gm		Stat	1 d	2–7 d	8–14 d	>14 d
1	Abebe FA et al. 201224	16.6	79.4	5.3	3.7	79.4	1.69	10.47	51.69	28.04	8.11	51.7
2	Afriyie DK et al. 201722	57.6	39.4	1.5	1.5	100	12	43.4	48.6	0	0	85.7
3	Ayele AA et al. 201816	1.5	76.9	1.5	20	80.1	0	5.1	25.9	37.2	31.8	53
4	Ayinalem GA et al. 201325	9.5	63.6	0.9	25.9	77.4	8.5	13.3	76.6	2.8	1.3	52.6
5	Bantie et al. 201426	–	–	–	–	86	–	–	–	–	–	82
6	Berhe YH et al. 201915	5.5	94.5	0	0	50.5	11.4	20	28.4	35.5	4.7	26.6
7	Eulambius M et al. 201927	19	74	0	1	18	0	7	88	5	0	78
8	Manirakiza L et al. 201928	72.9	22.9	6	3.6	31.2	15.6	50	32.2	2.2	0	55
9	Sasi P et al. 201929	87.7	11.1	0.5	0.5	0	0	15.6	33.9	48.3	2.2
10	Hussien LA. 201923	23.6	71.7	0.8	3.9	94.2	4.7	5.5	70.1	17.3	2.4	71.7
11	Negese S et al. 201730	0	73.5	0	26.5	87.8	0	1.2	83.9	13.6	1.2	18
12	Shimels T et al. 201531	0	78.6	18.6	2.8	95.8	5.1	14.5	68.1	9.3	3	91.6

Note: NB, some of the included studies did not report information on the appropriateness of daily dose, frequency and duration of ceftriaxone.

Abbreviations: Stat, the first single dose; ref, reference.